ArticleInternational journal of cancer2019

First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.

Ignacio Garrido-Laguna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.